Amgen uses StudyTeam to Enroll a Global Study 2 Weeks Ahead of Schedule

During study startup, clinical trials sponsors must balance study enrollment targets and expectations with the capabilities delivered by global sites. Beyond the traditional challenges that companies face with enrollment, Amgen also had to navigate issues created by the COVID-19 global pandemic that impacted daily activities and enrollment in clinical studies.  

 

Read the case study now.

Learn more about our work with Amgen

Amgen, one of the world’s largest independent biopharmaceutical companies, has adopted use of StudyTeam across their entire global research portfolio.

Reify Health’s StudyTeam Is Selected by Amgen Across Global Research Portfolio

Read the Blog Post

On-Demand Webinar: Enrolling a Global Study Ahead of Schedule (During a Pandemic)

Watch the Webinar

Amgen Increases Efficiencies in Working with Sites and Improves Enrollment Across Its Global Research Portfolio

Read the Case Study

About Reify Health

Reify Health provides cloud-based software that accelerates the development of new and life-saving therapies. We serve the global life science industry, including thousands of clinical research sites, the most innovative biotechs, and the world's largest biopharmaceutical companies.

Play the video to hear how StudyTeam can help you speed up enrollment.

 

Enroll intelligently. 

StudyTeam makes it radically easier for sites and sponsors to share recruitment insights and enroll with confidence.

 

Request a demo